Chemical Structure and Metabolism
Unlike endogenous catecholamines (such as epinephrine and norepinephrine), the phenylephrine hydrochloride molecule contains only a single hydroxyl group on the benzene ring. This structural difference holds major practical significance.
The enzyme catechol-O-methyltransferase (COMT) is unable to inactivate the drug. The clinical consequence of this is a longer duration of action compared to typical catecholamines. Furthermore, resistance to enzymatic degradation allows the drug to maintain efficacy even when administered orally.
Cardiovascular Effects
The primary mechanism of action involves the selective stimulation of postsynaptic $\alpha_1$-adrenergic receptors. The cardiovascular response consists of two components:
- Direct Effect: Stimulation of vascular smooth muscle receptors causes powerful vasoconstriction. This leads to a pronounced pressor effect—a significant rise in systemic blood pressure.
- Reflex Response: The acute elevation in blood pressure mechanically stimulates baroreceptors located in the aortic arch and carotid sinus. Signals are transmitted to the brain, reflexively increasing vagal tone (n. vagus). Conversely, the vasomotor center and sympathetic influences are inhibited.
Key Takeaway: The dominant cardiac effect becomes reflex bradycardia (decreased heart rate). Phenylephrine does not directly depress myocardial function; this is a secondary autonomic nervous system response to vasoconstriction.
Ophthalmic Effects
When administered as eye drops, the drug acts on intraocular structures. Stimulation of adrenergic receptors causes contraction of the iris dilator muscle, resulting in mydriasis (pupillary dilation).
Unlike muscarinic antagonists (atropine-like agents), phenylephrine does not affect accommodation. The ciliary muscle, which controls lens curvature, is predominantly innervated by the parasympathetic nervous system and does not respond to $\alpha$-adrenergic agonists. Consequently, the patient retains the ability to focus clearly on near objects.
Additionally, the drug can reduce intraocular pressure (IOP) in open-angle glaucoma.
Indications
The drug is widely used across various medical specialties:
- Systemic Hypotension: The goal is the emergency elevation of blood pressure. The solution is administered intravenously (effect lasts about 20 minutes), subcutaneously (40–50 minutes), or intramuscularly.
- Ophthalmology: Used for diagnostic or therapeutic pupillary dilation, as well as to lower IOP in open-angle glaucoma.
- Otolaryngology: Topical application causes vasoconstriction of the nasal mucosa, reducing edema in rhinitis. It is frequently combined with $H_1$-antihistamines (e.g., dimetinden in nasal decongestant sprays).
- Local Anesthesia: Adding phenylephrine to local anesthetic solutions induces local vasoconstriction. This prolongs the anesthetic duration and decreases systemic absorption and toxicity.
Side Effects and Contraindications
Severe peripheral vasoconstriction can lead to tissue ischemia, excessive spikes in blood pressure, and reflex bradycardia. Central nervous system side effects occasionally include headache and dizziness, while urinary retention may occur via urinary tract effects.
Contraindications include:
- Hypertension;
- Tendency to vasospasm (including coronary artery spasm);
- Endocrine disorders (hyperthyroidism);
- Closed-angle glaucoma.